Rady Children’s Hospital-San Diego (RCHSD) is an academic teaching hospital that is integrated with the University of California (UC San Diego) School of Medicine and UC San Diego Skaggs School of Pharmaceutical Sciences.
PGY2 Program Purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
The PGY2 Pharmacy Residency Program at Rady Children’s Hospital San Diego is a pediatric training program established in the year 2019. The program accepts one resident annually. The residency centers on the development of knowledge, attitude, and skills needed to provide pharmaceutical care in the specialized area of pediatrics with a focus on hematology/oncology. The resident will rotate in the areas of General Pediatrics, Pediatric ICU, Neonatal ICU, Solid Tumor, BMT/Cellular therapies, Leukemia and Lymphoma, Hematology, and Infections Disease/AMS, as well as chosen electives (i.e. Pain\Palliative Care, and Investigational Drug Services). The resident will have additional responsibilities including presentations, both formal and informal, as well as the Childhood Cancers Lecture for the Pediatric Pharmacotherapy Elective at the UCSD School of Pharmacy. The resident will also successfully complete a research project suitable for publication. This project will be presented at HOPA (Hematology Oncology Pharmacy Association) annual meeting.
The attending physicians at the Rady Children’s Peckham Center for Cancer and Blood Disorders treat more than 250 new pediatric patients every year with various childhood cancers, making it the largest pediatric cancer care center and only pediatric bone marrow transplant program serving San Diego, Riverside and Imperial counties. Rady Children’s is a part of the Children’s Oncology Group, the largest pediatric clinical trial organization in the world helping children with cancer. It also has a research alliance with UC San Diego, making it part of a National Cancer Institute-designated Comprehensive Cancer Center, and with St. Jude Children’s Research Hospital.
Diversity, Equity and Inclusion
The PGY1 and PGY2 programs at Rady Children’s Hospital are committed to fostering diversity, equity, and inclusion. We believe that a diverse and inclusive cohort of residents enriches our educational experiences, promotes innovation, and enhances health equity, health outcomes, and patient care.
We actively seek applicants from diverse backgrounds to ensure our resident group reflects the diverse communities we serve. By promoting culturally competent care and addressing health disparities, we strive to improve health equity for all.
Through our dedication to diversity, equity, and inclusion, we aim to cultivate a dynamic and inclusive learning environment that prepares residents to become compassionate healthcare leaders who can effectively address the healthcare needs of diverse patient populations.
Learning Experiences
The PGY2 residency will comprise core rotations in:
- Leukemia and Lymphoma
- Solid Tumor
- Hematology
- BMT/Cellular Therapies
- Infectious Disease/Antimicrobial Stewardship (AMS)
- General Pediatrics
- Pediatric ICU
- Neonatal ICU
- Central Pharmacy Staffing
- Informatics/Beacon
Elective rotations in Investigational Drug Services, Child and Adolescent Psychiatry Pain/Palliative Care.
Other elective experiences maybe developed based on resident interest and preceptor availability (i.e. Cardiac ICU, Solid Organ Transplant, Toxicology).
Residents are required to complete a Hematology/Oncology Research Project.
Teaching opportunities at UC San Diego School of Pharmacy.
Professional Meetings
Residents will be required to attend various professional meetings throughout the year, which may include ASHP’s (American Society of Health-System Pharmacists) Midyear meeting at which they will participate in recruitment efforts) and HOPA (Hematology Oncology Pharmacist Association). The resident will present their research at HOPA.
Requirements for Acceptance:
- Pharm.D. degree from ACPE accredited program
- Successful completion of PGY1 residency
- Application and Current CV through Phorcas, minimum 3 letters of recommendation
Benefits
We offer health, dental, vision and hospitalization insurance, vacation, holiday and professional leave. A set travel stipend for the year will be provided to support attendance at professional conferences such as HOPA, COG meetings and ASHP Midyear. See the Policy and Procedure Manual for additional benefit information.
Stipend
The current annual stipend is approximately $68,000.
Beginning Date
The residency program tentatively begins in the middle of July.
Application Procedure
- Applicants must participate in the ASHP Match and apply using PhORCAS at http://www.ashp.org/phorcas. Rady Children’s Hospital National Matching Service (NMS) Code: 611761
- Matched residents must be licensed Pharmacists in the State of California by November 1 of their appointed year.
Application Deadline
January 2, 2024
Contact
For additional information, contact Residency Program Director
Lawrence Alejandro, Pharm.D. BCPPS
Email: lalejandro@rchsd.org
Rady Children’s Hospital-San Diego
3020 Children’s Way, San Diego, CA 92123
Main Phone: 858-576-1700
Customer Service & Referrals: 800-788-9029